These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7505706)

  • 41. How can we improve patient-centered care of motor neuron disease?
    Hogden A; Paynter C; Hutchinson K
    Neurodegener Dis Manag; 2020 Apr; 10(2):95-101. PubMed ID: 32352344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The ethics of partial palliative care.
    Latimer EJ
    J Palliat Care; 1994; 10(3):107-10. PubMed ID: 7531227
    [No Abstract]   [Full Text] [Related]  

  • 43. Ethics and the oncologist.
    Pfeffer MR
    Med Law; 1993; 12(3-5):235-40. PubMed ID: 7694029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ALS--motor neuron disease: mechanism and development of new therapies.
    Rothstein JD
    J Vis Exp; 2007; (6):245. PubMed ID: 18997893
    [No Abstract]   [Full Text] [Related]  

  • 45. Management of motor neurone disease.
    Howard RS; Orrell RW
    Postgrad Med J; 2002 Dec; 78(926):736-41. PubMed ID: 12509691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Research and the associations: an era for partnership.
    Cardy P
    Palliat Med; 1993; 7(4 Suppl):3-9. PubMed ID: 7505707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Palliative care: principles and pracice. Section of Palliative Care, Ontario Medical Association.
    Latimer EJ; Dawson HR
    CMAJ; 1993 Mar; 148(6):933-6. PubMed ID: 7680601
    [No Abstract]   [Full Text] [Related]  

  • 48. Social work competencies in palliative and end-of-life care.
    Gwyther LP; Altilio T; Blacker S; Christ G; Csikai EL; Hooyman N; Kramer B; Linton J; Raymer M; Howe J
    J Soc Work End Life Palliat Care; 2005; 1(1):87-120. PubMed ID: 17387058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Megaslope, natural course, and historical controls in amyotrophic lateral sclerosis trials.
    Conradi S; Ronnevi LO
    Adv Neurol; 1995; 68():219-24. PubMed ID: 8787232
    [No Abstract]   [Full Text] [Related]  

  • 50. A promise for palliative care at the end-of-life.
    Farrell PM; Hammes B
    WMJ; 2001; 100(9):59, 66. PubMed ID: 11868521
    [No Abstract]   [Full Text] [Related]  

  • 51. [Patient education--support--help with decisions: ethical aspects in treatment of amyotrophic lateral sclerosis].
    Meran JG; Hamm M; Ganser A
    Wien Med Wochenschr; 1996; 146(9-10):190-4. PubMed ID: 9012209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Research, care and the associations: an era for partnership.
    Cardy P
    J Neurol Sci; 1994 Jul; 124 Suppl():1-5. PubMed ID: 7807134
    [No Abstract]   [Full Text] [Related]  

  • 53. [Problems in weaning of artificial ventilation: motor-neuron disease].
    Vos PE; van den Berg JP; van Kesteren RG; Wokke JH
    Ned Tijdschr Geneeskd; 1996 May; 140(18):997. PubMed ID: 8692318
    [No Abstract]   [Full Text] [Related]  

  • 54. Access to palliative care for people with motor neurone disease in New Zealand.
    McKenna C; MacLeod R
    N Z Med J; 2005 Sep; 118(1222):U1667. PubMed ID: 16222359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Health professionals' responses to multiple sclerosis and motor neurone disease.
    Carter H; McKenna C; MacLeod R; Green R
    Palliat Med; 1998 Sep; 12(5):383-94. PubMed ID: 9924601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Motor neurone disease.
    Nageshwaran S; Davies LM; Rafi I; Radunović A
    BMJ; 2014 Jul; 349():g4052. PubMed ID: 25008100
    [No Abstract]   [Full Text] [Related]  

  • 57. Supportive & palliative interventions in motor neurone disease: what we know from current literature?
    Cheng HWB; Chan KY; Chung YKJ; Choi CW; Chan CH; Cheng SC; Chan WH; Fung KS; Wong KY; Chan OMI; Man CW
    Ann Palliat Med; 2018 Jul; 7(3):320-331. PubMed ID: 29156920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cellular therapies in motor neuron diseases.
    Nayak MS; Kim YS; Goldman M; Keirstead HS; Kerr DA
    Biochim Biophys Acta; 2006; 1762(11-12):1128-38. PubMed ID: 16872810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mapping the journey: family carers' perceptions of issues related to end-stage care of individuals with muscular dystrophy or motor neurone disease.
    Dawson S; Kristjanson LJ
    J Palliat Care; 2003; 19(1):36-42. PubMed ID: 12710113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The ethics of end-of-life care for patients with ESRD.
    Davison SN
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):2049-57. PubMed ID: 22997341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.